Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation

Up to 84% of GLP-1 induced weight loss retained with Revita® versus 46% with shamat one year in patients receiving complete ...
Psychology Today

The Use of Games in Therapy: It’s Not Just Fun and Games

The value of therapists using games with children or teens in therapy sessions is sometimes misunderstood but can be a highly ...
Tech Times

Blood-Brain Barrier Crossed: Denali’s FDA Approval Unlocks Alzheimer’s Pipeline

Blood-brain barrier drug delivery reached a landmark: the FDA’s March 2026 accelerated approval of Denali Therapeutics’ ...
Zacks Small Cap Research on MSN

OTC Markets Life Sciences Investor Forum: Dr. Phillip Chan, CEO, and Pete Mariani, CFO, of CytoSorbents with Zacks SCR’s Tom Kerr, CFA

NASDAQ: CTSO Greg Young: Hello and welcome to the Life Sciences Investor Forum. On behalf of OTC Markets and our co-host, Zacks Small Cap Research, we're very pleased you have joined us. The next ...
The Lancet

Advancing the relevance of clinical trials for older patients

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...
BMJ Open

Building genetic healthcare together: an Australian co-production three-phase mixed-methods research protocol with people with intellectual disability

Introduction People with intellectual disability face significant barriers to accessing genetic healthcare, including during ...